** Shares of Sartorius SATG.DE slide 5.7% in early
Frankfurt trade after the Franco-German lab supplies maker
published Q1 numbers that missed analysts' expectations for
order intake and revenues
** "Would sell high prints as order intake expectations were
high," a local trader says, adding the company did not fulfill
hopes
** "We expect the shares to underperform by at least 5%
today," says J.P. Morgan, citing Q1 weak BPS orders, which came
in 10% below the expectations of the brokerage
** The broker also mentions soft quarter on Bioprocess
Solutions (BPS) revenues, which declined by 5% CER and missed by
5%
** The company Q1 order intake came in at 826.3 million
euros
** The stock is at the bottom of the German blue-chips index
.GDAXI
(Reporting by Anastasiia Kozlova)
((Anastasiia.Kozlova@thomsonreuters.com))